(Q38597241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Latent Membrane Protein 2 (LMP2) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2

Richard Longnecker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

Current Topics in Microbiology and Immunology

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

151-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

An auto-regulatory loop for EBV LMP2A involves activation of Notch

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Co-receptor and accessory regulation of B-cell antigen receptor signal transduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The B-cell antigen receptor: structure and function of primary, secondary, tertiary and quaternary components

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

B cell receptor signal strength determines B cell fate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Identification of UNC119 as a novel activator of SRC-type tyrosine kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

SYK inhibition and response prediction in diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Palmitoylation of oncogenic NRAS is essential for leukemogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

B cell antigen receptor signaling 101.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Early events in B cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Lysine-independent ubiquitination of Epstein-Barr virus LMP2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

WW domains provide a platform for the assembly of multiprotein networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

LMP2A does not require palmitoylation to localize to buoyant complexes or for function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

WW- and SH3-domain interactions with Epstein-Barr virus LMP2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Constitutive activation of Src family kinases in mouse embryos that lack Csk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Identification of a novel domain of Ras and Rap1 that directs their differential subcellular localizations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Regulation of the SRC family kinases by Csk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Antigen receptor tail clue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Crk family adaptor proteins trans-activate c-Abl kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Crystal structure of the Src family tyrosine kinase Hck

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Minimal protein domain requirements for the intracellular localization and self-aggregation of Epstein-Barr virus latent membrane protein 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_5

10.1007/978-3-319-22834-1_5

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428374%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference